Atlas Trials

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Clinical trial NCT04655404 · RECRUITING

Trial details

NCT number
NCT04655404
Sponsor
Nationwide Children's Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
High Grade GliomaDiffuse Intrinsic Pontine Glioma
Start date
2021-04-08
Primary completion
2026-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.